Geovax Labs (GOVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 11,424 | 18,107 | 19,539 | 20,843 | 9,884 |
| Receivables | 49 | N/A | N/A | N/A | 183 |
| TOTAL | $11,629 | $18,160 | $19,657 | $20,961 | $10,235 |
| Non-Current Assets | |||||
| PPE Net | 157 | 169 | 150 | 143 | 148 |
| Other Non-Current Assets | 11 | 11 | 11 | 11 | 11 |
| TOTAL | $168 | $180 | $161 | $154 | $159 |
| Total Assets | $11,797 | $18,340 | $19,817 | $21,116 | $10,394 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,058 | 289 | 290 | 233 | 268 |
| Accrued Expenses | 3,378 | 46 | 69 | 37 | 359 |
| TOTAL | $5,435 | $336 | $359 | $452 | $810 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 12 | 15 |
| Other Non-Current Liabilities | 2,000 | 0 | 0 | 0 | 0 |
| TOTAL | $2,000 | $N/A | $N/A | $12 | $15 |
| Total Liabilities | $7,435 | $336 | $359 | $464 | $825 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 473 | 426 | 422 | 421 | 421 |
| Common Shares | 6 | 6 | 6 | 6 | 4 |
| Retained earnings | -64,376 | -50,633 | -48,682 | -47,368 | -45,806 |
| Other shareholders' equity | 0 | 0 | 0 | 76 | 0 |
| TOTAL | $4,362 | $18,004 | $19,458 | $20,651 | $9,569 |
| Total Liabilities And Equity | $11,797 | $18,340 | $19,817 | $21,115 | $10,394 |